Skip to main content
Equibles

Invesco Ltd.

Position in SYRE — Spyre Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,701,628
+$4,023,878 QoQ
Shares Held
120,541
-9.0% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. SYRE ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,701,628 120,541
2026-03-31 $6,677,750 132,390
2025-12-31 $4,944,597 150,934
2025-09-30 $849,764 50,702
2025-06-30 $519,158 34,680
2025-03-31 $406,713 25,207
2024-12-31 $457,753 19,663
2024-09-30 $4,054,402 137,858
2024-06-30 $384,715 16,364
2024-03-31 $5,787,283 152,578